Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | GABRP | O00591 | 2/20 | 0.39 |
| ▸ | GABRD | O14764 | 2/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8673503 | 0.89 | ALDH1A1 (0.42) | ALDH1A1MAPTCYP3A4KDM4EGAA | |
| SCHEMBL6690303 | 0.86 | ALDH1A1 (0.50) | ALDH1A1CYP3A4TSHRMAPK1CA2 | |
| SCHEMBL128530 | 0.85 | HTT (0.44) | ALDH1A1CYP3A4KDM4ETSHRMAPK1 | |
| SCHEMBL6057194 | 0.84 | ALDH1A1 (0.48) | ALDH1A1CYP3A4TSHRMAPK1CA2 | |
| Aminobenzoic Acid SCHEMBL8537849 | 0.83 | ALDH1A1 (0.47) | ALDH1A1MAPTCYP3A4KDM4EGAA | |
| SCHEMBL9988562 | 0.82 | TSHR (0.46) | ALDH1A1TSHRMAPK1PPARAPRSS1 | |
| SCHEMBL45364 | 0.82 | ALDH1A1 (0.49) | ALDH1A1MAPTCYP3A4KDM4EGAA | |
| SCHEMBL16266683 | 0.82 | TDP1 (0.41) | ALDH1A1CYP3A4TSHRMAPK1CA2 | |
| SCHEMBL11331262 | 0.81 | ALDH1A1 (0.44) | ALDH1A1CYP3A4KDM4ETSHRMAPK1 | |
| SCHEMBL6025276 | 0.81 | L3MBTL1 (0.47) | ALDH1A1MAPTCYP3A4KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2838886-A1 | DIETHYLHEXYL BUTAMIDO TRIAZONE WITH HIGH PURITY, AND PROCESS FOR ITS PREPARATION | 3V SIGMA S.p.A (IT) | 2015-02-25 | — | — | EP | claimed |
| WO-2013156270-A1 | DIETHYLHEXYL BUTAMIDO TRIAZONE WITH HIGH PURITY, AND PROCESS FOR ITS PREPARATION | 3V SIGMA S.P.A. (IT) | 2013-10-24 | — | — | WO | claimed |
| US-20130280190-A1 | DIETHYLHEXYL BUTAMIDO TRIAZONE WITH HIGH PURITY, AND PROCESS FOR ITS PREPARATION | 3V SIGMA S.P.A. (IT) | 2013-10-24 | — | — | US | claimed |
| CN-1073947-A | Novel sunscreen metal complexes | RICHARDSON VICKS INC (US) | 1993-07-07 | — | — | CN | claimed |
| WO-2026104705-A2 | PROCESS FOR THE PRODUCTION OF C6-C18 ALKYL ESTERS OF 4-AMINOBENZOIC ACID | DSM IP ASSETS B.V. (NL) | 2026-05-21 | — | — | WO | disclosed |
| EP-3275872-B1 | NEW TRIAZINE COMPOUNDS AS PHOTOSTABILISING AGENTS | 3V SIGMA SPA (IT) | 2021-05-05 | — | — | EP | disclosed |
| EP-3578558-B1 | HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS | 3V SIGMA SPA (IT) | 2021-02-24 | — | — | EP | disclosed |
| EP-3578558-A1 | HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS | 3V SIGMA S.p.A (IT) | 2019-12-11 | — | — | EP | disclosed |
| US-10457650-B2 | Triazine compounds as photostabilizing agents | 3V SIGMA S.P.A. (IT) | 2019-10-29 | — | — | US | disclosed |
| US-20180030001-A1 | NEW TRIAZINE COMPOUNDS AS PHOTOSTABILIZING AGENTS | 3V SIGMA S.P.A. (IT) | 2018-02-01 | — | — | US | disclosed |
| EP-3275872-A1 | NEW TRIAZINE COMPOUNDS AS PHOTOSTABILISING AGENTS | 3V SIGMA S.p.A (IT) | 2018-01-31 | — | — | EP | disclosed |
| EP-2838886-A1 | DIETHYLHEXYL BUTAMIDO TRIAZONE WITH HIGH PURITY, AND PROCESS FOR ITS PREPARATION | 3V SIGMA S.p.A (IT) | 2015-02-25 | — | — | EP | disclosed |
| EP-0832642-B1 | Derivatives of Benzoxazole useful as uv filters | 3V SIGMA SPA (IT) | 2003-12-03 | — | — | EP | disclosed |
| CN-1063626-C | Leave-on facial emulsion compositions | RICHARSON VICKS INC (US) | 2001-03-28 | — | — | CN | disclosed |
| CN-1283099-A | Skin care compositions and method of improving skin apperance | PROCTER & GAMBLE (US) | 2001-02-07 | — | — | CN | disclosed |
| CN-1281354-A | Topical composition for regulating oily/shiny appearance of skin | PROCTER & GAMBLE (US) | 2001-01-24 | — | — | CN | disclosed |
| CN-1229354-A | Skin lightening composition | PROCTER & GAMBLE (US) | 1999-09-22 | — | — | CN | disclosed |
| US-5744127-A | SUNSCREENS IN COSMETICS AND STABILIZATION OF SYNTHETIC POLYMERS | 3V INC. (US) | 1998-04-28 | — | — | US | disclosed |
| EP-0832642-A2 | Derivatives of Benzoxazole useful as uv filters | 3V SIGMA S.p.A (IT) | 1998-04-01 | — | — | EP | disclosed |
| CN-1063038-A | Retain in facial emulsion compositions | RICHARDSON VICKS INC (US) | 1992-07-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030001-A1 | NEW TRIAZINE COMPOUNDS AS PHOTOSTABILIZING AGENTS | TOP2A, XDH, TOP2B | ALDH1A1 407/4885MAPT 285/4885CYP3A4 554/4885 |
| US-20130280190-A1 | DIETHYLHEXYL BUTAMIDO TRIAZONE WITH HIGH PURITY, AND PROCESS FOR ITS PREPARATION | HLA-B, CUTA, AADAC | ALDH1A1 725/4885MAPT 3253/4885CYP3A4 239/4885 |
| US-10457650-B2 | Triazine compounds as photostabilizing agents | TOP2A, TOP2B, PRXL2A | ALDH1A1 342/4885MAPT 223/4885CYP3A4 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.